Cost-effectiveness of clopidogrel in Mexico: A long term analysis

被引：0
|
作者：
Jerjes-Sanchez, C.
Trujillo, A.
Ramos, M. A.
Hernandez, I
Alvarado, R.
Cruz, A.
Rangel, F. J.
Morales, E.
机构：
[1] IMSS, Hosp Enfermedades Cardiovasc & Torax, Monterrey, Nuevo Leon, Mexico
[2] Hosp Gen Zona 57, Mexico City, DF, Mexico
[3] UMAE CM Raza, Mexico City, DF, Mexico
[4] Hosp Juarez Mexico, Mexico City, DF, Mexico
[5] ISSSTE Durango, Durango, Mexico
[6] Hosp PEMEX Norte, Mexico City, DF, Mexico
[7] Cardiometab Res Unit, Aguascalientes, Mexico
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63642-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A345 / A345
页数：1
相关论文
共 50 条
  • [21] A COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL VERSUS ASPIRIN IN PATIENTS WITH ATHEROTHROMBOSIS IN GREECE
    Kourlaba, G.
    Fragoulakis, V
    Maniadakis, N.
    VALUE IN HEALTH, 2011, 14 (07) : A378 - A378
  • [22] A MODEL-BASED COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL PHARMACOGENOMIC TESTING
    Lubomirov, R.
    Borobia, A. M.
    Carcas, A. J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 33 - 33
  • [23] Long-Term Cost-Effectiveness Analysis of Infliximab in the Management of Ulcerative Colitis
    Ung, Victoria
    Lee, Thomas W.
    Wang, Haili
    Kroeker, Karen I.
    Thanh X. Nguyen
    Ohinmaa, Arto
    Jacobs, Philip
    Wong, Karen
    Fedorak, Richard N.
    GASTROENTEROLOGY, 2011, 140 (05) : S201 - S201
  • [24] Preventing Pressure Ulcers in Long-term Care A Cost-effectiveness Analysis
    Ba Pham
    Stern, Anita
    Chen, Wendong
    Sander, Beate
    John-Baptiste, Ava
    Thein, Hla-Hla
    Gomes, Tara
    Wodchis, Walter P.
    Bayoumi, Ahmed
    Machado, Marcio
    Carcone, Steven
    Krahn, Murray
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (20) : 1839 - 1847
  • [25] The long term effectiveness and cost-effectiveness of initiating treatment for ocular hypertension
    van Gestel, Aukje
    Schouten, Jan S. A. G.
    Beckers, Henny J. M.
    Severens, Johan L.
    Hendrikse, Fred
    Webers, Carroll A. B.
    ACTA OPHTHALMOLOGICA, 2014, 92 (06) : 513 - 523
  • [26] Long term cost-effectiveness and cost-utility analysis for smoking cessation in Czech Republic
    Skoupa, J.
    Dolezal, T.
    Hajek, P.
    Kovar, P.
    VALUE IN HEALTH, 2008, 11 (03) : A272 - A272
  • [27] Long-term cost-effectiveness of clopidogrel in acute coronary syndromes based on CURE and PCI-CURE in Poland
    Pietrasik, AL
    Niewada, M
    Budaj, A
    Kochman, J
    Horszczaruk, G
    Gabriel, S
    Spiesser, J
    Yuan, Y
    VALUE IN HEALTH, 2005, 8 (06) : A98 - A98
  • [28] COST-BENEFIT-ANALYSIS VERSUS COST-EFFECTIVENESS ANALYSIS FOR THE EVALUATION OF LONG-TERM CARE PROGRAMS
    TORRANCE, GW
    STODDART, GL
    DRUMMOND, MF
    GAFNI, A
    HEALTH SERVICES RESEARCH, 1981, 16 (04) : 474 - 476
  • [29] COST-EFFECTIVENESS OF MARAVIROC FOR HIV IN MEXICO
    Contreras-Hernandez, I
    Becker, D. L.
    Chancellor, J., V
    Kuehne, F.
    Mould-Quevedo, J.
    Marfatia, S.
    VALUE IN HEALTH, 2009, 12 (03) : A116 - A116
  • [30] Short and long term cost-effectiveness analysis of clopidogrel in patients with acute coronary syndrome without ST segment elevation (ACS) in Scandinavian countries
    Lindgren, P
    Jönsson, B
    Spiesser, J
    Carita, P
    Gabriel, S
    VALUE IN HEALTH, 2003, 6 (06) : 621 - 621
12345